Consensus
Provides easy interoperability with streamlined workflows in a simple platform that keeps you connected through each patient’s continuum of care.
Launch date
Market cap
€382m
Enterprise valuation
€936m (Public information from Sep 2024)
Share price
$23.38 CCSI
Los Angeles California (HQ)
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 678m | 618m | 362m | 363m | 344m | 343m | 324m |
| % growth | 110 % | (9 %) | (41 %) | - | (5 %) | - | (5 %) |
| EBITDA | 346m | 194m | 166m | 166m | 186m | 188m | 185m |
| % EBITDA margin | 51 % | 31 % | 46 % | 46 % | 54 % | 55 % | 57 % |
| Profit | 153m | 106m | 72.4m | 77.3m | 91.1m | 93.0m | 104m |
| % profit margin | 23 % | 17 % | 20 % | 21 % | 26 % | 27 % | 32 % |
| EV / revenue | - | 1.9x | 4.9x | 3.2x | 3.0x | 2.7x | 1.4x |
| EV / EBITDA | - | 5.9x | 10.7x | 6.9x | 5.5x | 5.0x | 2.5x |
| R&D budget | 22.8m | 24.4m | 10.0m | 7.7m | - | - | - |
| R&D % of revenue | 3 % | 4 % | 3 % | 2 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Corporate spinout | ||
| N/A | N/A Valuation: $416m 0.6x EV/LTM Revenues 1.2x EV/LTM EBITDA | IPO | |
| Total Funding | - | ||
